Literature DB >> 2882402

Inhibitory effect of norepinephrine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.

T Suda, F Yajima, N Tomori, T Sumitomo, Y Nakagami, T Ushiyama, H Demura, K Shizume.   

Abstract

Effects of catecholamines on immunoreactive corticotropin-releasing factor (I-CRF) release from the rat hypothalamus were examined using a rat hypothalamic perifusion system and a rat CRF RIA in vitro. Norepinephrine had a potent inhibitory effect on I-CRF release in a dose-dependent manner at 0.1 nM-1 microM concentrations, but dopamine did not. This inhibitory effect of norepinephrine was completely blocked by propranolol, but only partially blocked by phentolamine. Isoproterenol also had a potent inhibitory effect at 0.01-100 nM concentrations, and a high dose of phenylephrine (10 nM) inhibited I-CRF release. Clonidine did not influence I-CRF release. These results suggest that norepinephrine inhibits I-CRF release mainly through the beta-adrenergic receptor and partially through the alpha 1-receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882402     DOI: 10.1016/0024-3205(87)90012-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Authors:  A E Calogero; W T Gallucci; G P Chrousos; P W Gold
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

2.  Alpha 2- and beta-adrenergic stimulation of corticosterone secretion in rats.

Authors:  W M Daniels; A Jaffer; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1993-02       Impact factor: 3.996

3.  Influence of noradrenergic input into the hypothalamic paraventricular nucleus on fever in the guinea-pig.

Authors:  M Unger; G Merker; J Roth; E Zeisberger
Journal:  Pflugers Arch       Date:  1991-10       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.